Literature DB >> 23119424

Studies on the blood nicotine level in the oral and oropharyngeal cancers of habitual tobacco users.

B Choudhury1.   

Abstract

Entities:  

Year:  1998        PMID: 23119424      PMCID: PMC3465063          DOI: 10.1007/BF03006997

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


× No keyword cloud information.
  4 in total

Review 1.  Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future directions.

Authors:  D Hoffmann; S S Hecht
Journal:  Cancer Res       Date:  1985-03       Impact factor: 12.701

2.  Influence of smoking parameters on the delivery of tobacco-specific nitrosamines in cigarette smoke--a contribution to relative risk evaluation.

Authors:  S Fischer; B Spiegelhalder; R Preussmann
Journal:  Carcinogenesis       Date:  1989-06       Impact factor: 4.944

3.  Tumorigenic activity of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanol (iso-NNAL) and N'-nitrosonornicotine (NNN) on topical application to Sencar mice.

Authors:  E J LaVoie; G Prokopczyk; J Rigotty; A Czech; A Rivenson; J D Adams
Journal:  Cancer Lett       Date:  1987-11       Impact factor: 8.679

4.  Carcinogenic effect of tobacco smoking and alcohol drinking on anatomic sites of the oral cavity and oropharynx.

Authors:  P Boffetta; A Mashberg; R Winkelmann; L Garfinkel
Journal:  Int J Cancer       Date:  1992-10-21       Impact factor: 7.396

  4 in total
  2 in total

1.  A cellular model to mimic exhaled cigarette smokeinduced lung microvascular endothelial cell injury and death.

Authors:  Jianliang Zhang; Noah Juedes; Vikram M Narayan; Bingfang Yue; Alan L Rockwood; Nadia L Palma; Jawaharlal M Patel
Journal:  Int J Clin Exp Med       Date:  2010-07-31

2.  Nicotine induces neutrophil extracellular traps.

Authors:  Ava Hosseinzadeh; Paul R Thompson; Brahm H Segal; Constantin F Urban
Journal:  J Leukoc Biol       Date:  2016-06-16       Impact factor: 4.962

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.